Bromoacetylalprenololmenthane (BAAM or BrAAM) is a β adrenergic receptor agonist.[1]
![]() | |
Names | |
---|---|
IUPAC name
2-bromo-N-[2-[4-[[2-hydroxy-3-(2-prop-2-enylphenoxy)propyl]amino]-4-methylcyclohexyl]propan-2-yl]acetamide
| |
Identifiers | |
3D model (JSmol)
|
|
Abbreviations | BAAM, BrAAM |
ChEMBL | |
ChemSpider | |
MeSH | Bromoacetylalprenololmenthane |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C24H37BrN2O3 | |
Molar mass | 481.475 g·mol−1 |
log P | 4.14 |
Acidity (pKa) | 13.844 |
Basicity (pKb) | 0.153 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
References
edit- ^ Rainer-Joachim; Matthys Staehelin (20 April 1987). "Bromoacetylalprenololmenthane binding to β-receptors modulates the rate of hormone-induced internalization but not desensitization in S49 cells". FEBS Letters. 214 (2): 323–326. doi:10.1016/0014-5793(87)80079-0. PMID 3032686.